Domain/Instrument | Rationale | Time point | ||
---|---|---|---|---|
Baseline | 34Â day follow-up | 90Â day follow-up | ||
General measures, health status and other key characteristics | ||||
 Demographic characteristics (e.g., race, ethnicity, primary language of choice) | Description, moderators | X |  |  |
 Hospitalization information (i.e., reason for and days of hospitalization) | Description, moderator | X |  |  |
 General life, economic, housing, and criminal justice status | Description, moderators | X |  |  |
 Usual source of medical care | Description, moderator | X |  |  |
 Technology access and comfort | Description, moderator | X |  |  |
 Cognitive function (Montreal Cognitive Assessment [MoCA]) [103] | Description, moderator | X |  | X |
 Self-reported medical comorbidities [104] | Description | X |  |  |
Moderator | Xa | Â | Â | |
 Post-traumatic stress disorder | Description, moderator | X |  |  |
 Patient reported outcomes (PROMIS-Preference [PROPr]) [108] | Moderators, Health utility score | Xa | Xa | Xa |
 Project ENHANCE Informed consent quiz | Description | Xa |  |  |
Alcohol-related measures | ||||
 Alcohol use history (lifetime, past 30 days) | Description, moderator | X |  |  |
 AUDIT-C [43] | Description, moderator | X |  |  |
 Alcohol symptom checklist [46] | Description, moderator | X |  | X |
 Alcohol timeline followback [109] | Secondary outcome | X | X | X |
Primary outcome | X | Xb | Xb | |
 Phosphatidylethanol (PEth) [111] | Secondary outcome | X | X | X |
 Perspectives on treatment for alcohol use disorder [112, 113] | Description, moderator | X |  |  |
 Alcohol readiness ruler | Description, moderator | Xa | Xb | Xb |
 Alcohol abstinence self-efficacy scale [114] | Mediator | Xa | Xa | Xa |
 Short Inventory of problems-revised [115] | Secondary outcome | Xa |  | Xa |
Other substance use-related measures | ||||
 Drug use, past 30 days and age of first use | Moderators | X |  |  |
 Opioid use disorder symptoms [116] | Moderator | X |  |  |
 Severity of drug use problems (ASSIST Lite) [117] | Moderator | X |  | X |
 Drug timeline followback | Moderator | X | X | X |
 Substance use treatment history | Description | X |  |  |
 Family history | Moderator | X |  |  |
Additional social determinants of health | ||||
 Health disparities and safety screening tool, adapted [118, 119] | Moderators | Xa |  |  |
 Medical mistrust and discrimination assessment [120] | Moderator | Xa |  |  |
 Everyday discrimination scale [121] | Moderator | Xa |  |  |
 Perceived racial discrimination-adapted | Moderator | Xa |  |  |
 Immigration policy enforcement and related stress [122, 123] | Moderator | Xa |  |  |
 Multidimensional acculturative stress inventory for adults of Mexican origin [124] | Moderator | Xa |  |  |
 Multigroup ethnic identity measure-revised [125] | Moderator | Xa |  |  |
Treatment services and adverse events | ||||
Treatment utilization and cost, mediator | X | X | Â | |
 Adverse events (SAFTEE) [129] | Safety outcome |  | X | X |
Process measures | ||||
 Project EHNANCE session completion, duration | Process | BNI and telephone booster | ||
 Yale adherence and competence rating scale, adapted [130] | Intervention fidelity | BNI sessions only | ||
Implementation-related measures | ||||
 Cost-related data | Cost effectiveness | X | X | X |
 Participant satisfaction | Evaluation |  | Xa | Xa,c |